Triplet Regimen Bests Single-Agent Cabometyx in Soft Tissue Sarcoma
Adding Opdivo and Yervoy to Cabometyx led to improved progression-free survival and disease control rates in patients with soft tissue sarcoma, recent research showed.
Source: curetoday.com